New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on: August 28,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on:August 28,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on: June 11,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on:June 11,2024

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone

Updated on: January 30,2024

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone

Updated on:January 30,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on: February 20,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on:February 20,2024

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on: December 30,2023

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on:December 30,2023

Using cryo-shocked tumor cells to fight lung cancer

by Bob Yirka , Medical XpressSchedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk8264A team o

Updated on: April 06,2024

Using cryo-shocked tumor cells to fight lung cancer

by Bob Yirka , Medical XpressSchedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk8264A team o

Updated on:April 06,2024

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i

Updated on: January 26,2024

Knocking out part of the innate immune system to improve cancer therapy

by Justin Jackson , Medical XpressCredit: CC0 Public DomainResearchers at Shanghai Jiao Tong University School of Medicine, China, have discovered that shutting down part of the innate immune system i

Updated on:January 26,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on: February 18,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on:February 18,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on: August 28,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on:August 28,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on: June 01,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on:June 01,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

Study highlights promising drug combination for treating resistant breast cancer

by Lisa Marshall,University of Colorado at BoulderCredit:Cell(2023). DOI: 10.1016/j.cell.2023.05.013Cancer cells are even smarter than scientists previously believed, according to ne

Updated on: February 03,2024

Study highlights promising drug combination for treating resistant breast cancer

by Lisa Marshall,University of Colorado at BoulderCredit:Cell(2023). DOI: 10.1016/j.cell.2023.05.013Cancer cells are even smarter than scientists previously believed, according to ne

Updated on:February 03,2024